In Silico Molecular Characterization of Cysteine Protease YopT from Yersinia pestis by Homology Modeling and Binding Site Identification.

IF 2 Q3 PHARMACOLOGY & PHARMACY
Drug Target Insights Pub Date : 2014-01-13 eCollection Date: 2014-01-01 DOI:10.4137/DTI.S13529
Md Anayet Hasan, S M Alauddin, Mohammad Al Amin, Suza Mohammad Nur, Adnan Mannan
{"title":"In Silico Molecular Characterization of Cysteine Protease YopT from Yersinia pestis by Homology Modeling and Binding Site Identification.","authors":"Md Anayet Hasan,&nbsp;S M Alauddin,&nbsp;Mohammad Al Amin,&nbsp;Suza Mohammad Nur,&nbsp;Adnan Mannan","doi":"10.4137/DTI.S13529","DOIUrl":null,"url":null,"abstract":"<p><p>Plague is a major health concern and Yersinia pestis plays the central causal role in this disease. Yersinia pestis has developed resistance against the commonly available drugs. So, it is now a key concern to find a new drug target. Cysteine protease YopT enzyme is an important factor used by Yersinia pestis for pathogenesis in its host and it has the anti-phagocytic function of removal of C-termini lipid modification. The 3D structure of cysteine protease YopT of Yersinia pestis was determined by means of homology modeling through multiple alignments followed by intensive optimization and validation. The modeling was done by Phyre 2 and refined by ModRefiner. The obtained model was verified with structure validation programs such as PROCHECK, verify 3D and ERRAT for reliability. Interacting partners and active sites were also determined. PROCHECK analysis showed that 93% of the residues are in the most favored region, 5.9% are in the additional allowed region and 1.1% are in the generously allowed region of the Ramachandran plot. The verify 3D value of 0.78 indicates that the environmental profile of the model is good. SOPMA is employed for calculation of the secondary structural features of cysteine protease YopT. Active site determination through CASTp proposes that this protein can be utilized as a potential drug target. However, these findings should further be confirmed by wet lab studies for a targeted therapeutic agent design against Yersinia pestis. </p>","PeriodicalId":11326,"journal":{"name":"Drug Target Insights","volume":"8 ","pages":"1-9"},"PeriodicalIF":2.0000,"publicationDate":"2014-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4137/DTI.S13529","citationCount":"19","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Target Insights","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4137/DTI.S13529","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 19

Abstract

Plague is a major health concern and Yersinia pestis plays the central causal role in this disease. Yersinia pestis has developed resistance against the commonly available drugs. So, it is now a key concern to find a new drug target. Cysteine protease YopT enzyme is an important factor used by Yersinia pestis for pathogenesis in its host and it has the anti-phagocytic function of removal of C-termini lipid modification. The 3D structure of cysteine protease YopT of Yersinia pestis was determined by means of homology modeling through multiple alignments followed by intensive optimization and validation. The modeling was done by Phyre 2 and refined by ModRefiner. The obtained model was verified with structure validation programs such as PROCHECK, verify 3D and ERRAT for reliability. Interacting partners and active sites were also determined. PROCHECK analysis showed that 93% of the residues are in the most favored region, 5.9% are in the additional allowed region and 1.1% are in the generously allowed region of the Ramachandran plot. The verify 3D value of 0.78 indicates that the environmental profile of the model is good. SOPMA is employed for calculation of the secondary structural features of cysteine protease YopT. Active site determination through CASTp proposes that this protein can be utilized as a potential drug target. However, these findings should further be confirmed by wet lab studies for a targeted therapeutic agent design against Yersinia pestis.

鼠疫耶尔森菌半胱氨酸蛋白酶YopT的同源性建模和结合位点鉴定
鼠疫是一个主要的卫生问题,鼠疫耶尔森菌在该病中起主要的致病作用。鼠疫耶尔森氏菌对常用药物产生了耐药性。因此,寻找一种新的药物靶点是现在的一个关键问题。半胱氨酸蛋白酶YopT酶是鼠疫耶尔森菌在宿主体内致病的重要因子,具有清除c端脂质修饰的抗吞噬功能。通过同源性建模、多次比对、强化优化和验证,确定鼠疫菌半胱氨酸蛋白酶YopT的三维结构。建模由Phyre 2完成,并由ModRefiner进行细化。利用PROCHECK、verify 3D和ERRAT等结构验证程序对模型进行了可靠性验证。还确定了相互作用的伙伴和活动地点。PROCHECK分析表明,Ramachandran地块93%的残基位于最有利区,5.9%位于附加允许区,1.1%位于慷慨允许区。验证的三维值为0.78,表明模型的环境轮廓良好。采用SOPMA计算半胱氨酸蛋白酶YopT的二级结构特征。通过CASTp测定活性位点提示该蛋白可作为潜在的药物靶点。然而,这些发现应该通过设计针对鼠疫耶尔森菌的靶向治疗剂的湿实验室研究进一步得到证实。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug Target Insights
Drug Target Insights PHARMACOLOGY & PHARMACY-
CiteScore
2.70
自引率
0.00%
发文量
5
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信